<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Terlipressin</title><link>https://peptidescanner.com/peptides/terlipressin/</link><description>Versioned, source-linked PeptideScanner evidence objects for Terlipressin. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/terlipressin.xml" rel="self" type="application/rss+xml"/><item><title>ClinicalTrials.gov record NCT00089570</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00089570-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00089570-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct00089570-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-10-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00115947</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00115947-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00115947-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct00115947-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2006-03-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00369694</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00369694-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00369694-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct00369694-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2008-09-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00370253</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00370253-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00370253-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct00370253-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2008-04-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00628160</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00628160-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00628160-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct00628160-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-02-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00986817</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00986817-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00986817-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct00986817-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-06-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01143246</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01143246-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01143246-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct01143246-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-11-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01373606</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01373606-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01373606-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct01373606-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-02-14. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01637454</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01637454-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01637454-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct01637454-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-07-11. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02059460</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02059460-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02059460-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct02059460-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-12-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02588716</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02588716-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02588716-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct02588716-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-12-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02718599</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02718599-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02718599-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct02718599-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-12-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02757703</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02757703-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02757703-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct02757703-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2016-05-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02770716</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02770716-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02770716-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct02770716-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-11-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03107091</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03107091-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03107091-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct03107091-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-07-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03395574</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03395574-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03395574-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct03395574-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2018-12-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03572088</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03572088-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03572088-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct03572088-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-05-22. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03584087</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03584087-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03584087-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct03584087-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-12-16. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03822091</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03822091-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03822091-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct03822091-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-05-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04358016</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04358016-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04358016-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct04358016-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2020-04-22. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04416282</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04416282-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04416282-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct04416282-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-04-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04460560</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04460560-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04460560-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct04460560-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-10-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04961528</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04961528-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04961528-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct04961528-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-04-23. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05242783</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05242783-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05242783-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct05242783-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-06-25. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06108362</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06108362-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06108362-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct06108362-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06256432</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06256432-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06256432-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct06256432-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-04-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT06855758</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct06855758-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct06855758-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct06855758-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07252401</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07252401-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07252401-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct07252401-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-08-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07304466</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07304466-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07304466-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct07304466-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-04-29. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT07719933</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct07719933-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct07719933-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#clinicaltrials-gov-nct07719933-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-07-28. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA022231</title><link>https://peptidescanner.com/stories/fda-drugs-nda022231/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda022231:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#fda-drugs-nda022231-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2022-09-14. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2020-14719</title><link>https://peptidescanner.com/stories/federal-register-2020-14719/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2020-14719:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#federal-register-2020-14719-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2020-07-08. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2024-03300</title><link>https://peptidescanner.com/stories/federal-register-2024-03300/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2024-03300:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#federal-register-2024-03300-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2024-02-16. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.</title><link>https://peptidescanner.com/stories/pubmed-pmid-18683478-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-18683478-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-18683478-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-11-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Meta-analysis of terlipressin in treatment of hepatorenal syndrome: an update].</title><link>https://peptidescanner.com/stories/pubmed-pmid-19950571-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19950571-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-19950571-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin in hepatorenal syndrome: a systematic review and meta-analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20306131-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20306131-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-20306131-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22075285-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22075285-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-22075285-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-01. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Noradrenaline vs. terlipressin in the treatment of hepatorenal syndrome: a randomized study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22322237-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22322237-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-22322237-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-12-19. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin for hepatorenal syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22972083-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22972083-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-22972083-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Noradrenaline vs terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23601499-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23601499-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-23601499-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Noradrenaline or terlipressin for hepatorenal syndrome?</title><link>https://peptidescanner.com/stories/pubmed-pmid-26334297-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26334297-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-26334297-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin versus noradrenaline in the treatment of hepatorenal syndrome: systematic review with meta-analysis and full economic evaluation.</title><link>https://peptidescanner.com/stories/pubmed-pmid-26649801-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-26649801-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-26649801-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27633962-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27633962-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-27633962-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-27. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Comparison of 12-Hour with 72-Hour Terlipressin Therapy for Bleeding Esophageal Varices.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28689520-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28689520-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-28689520-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29943803-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29943803-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-29943803-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.</title><link>https://peptidescanner.com/stories/pubmed-pmid-30474439-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-30474439-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-30474439-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-03-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-31920672-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-31920672-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-31920672-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-09-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].</title><link>https://peptidescanner.com/stories/pubmed-pmid-31941255-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-31941255-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-31941255-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Role of Terlipressin and Albumin for Hepatorenal Syndrome in Liver Transplantation.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32574418-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32574418-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-32574418-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-03-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32676484-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32676484-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-32676484-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-05-06. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-33657294-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-33657294-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-33657294-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-05-18. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>RATIONAL FOR CONTINUING TERLIPRESSIN AFTER ENDOSCOPIC VARICEAL LIGATION IN ACUTE VARICEAL HAEMORRHAGE NEEDS FURTHER EVIDENCE: A PILOT STUDY.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35442343-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35442343-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-35442343-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-04-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Respiratory events with terlipressin and albumin in hepatorenal syndrome: A review and clinical guidance.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35838488-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35838488-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-35838488-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37548701-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37548701-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-37548701-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-05-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin for hepatorenal syndrome.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38353275-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38353275-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-38353275-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-07-29. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>From past to present to future: Terlipressin and hepatorenal syndrome-acute kidney injury.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38353565-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38353565-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-38353565-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38526204-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38526204-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-38526204-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Formulary Drug Reviews: Terlipressin.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38560548-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38560548-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-38560548-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-12-02. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin versus placebo or noradrenalin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39295934-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39295934-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-39295934-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-09-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The Application of Terlipressin in the Management of Ascites in Liver Cirrhosis: Current Status and Prospects.</title><link>https://peptidescanner.com/stories/pubmed-pmid-39618221-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-39618221-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-39618221-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-12-05. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin for Hepatorenal Syndrome in Patients With Early-Stage Acute-on-Chronic Liver Failure.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41200852-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41200852-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-41200852-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41204083-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41204083-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-41204083-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Terlipressin in paediatric hepatorenal syndrome-acute kidney injury (HRS-AKI).</title><link>https://peptidescanner.com/stories/pubmed-pmid-41711944-terlipressin/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41711944-terlipressin:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/terlipressin.json#pubmed-pmid-41711944-terlipressin-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
